Cargando…

Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques

Today, efficient delivery of sorafenib to hepatocellular carcinoma remains a challenge for current drug formulation strategies. Incorporating the lipophilic molecule into biocompatible and biodegradable theranostic nanocarriers has great potential for improving the efficacy and safety of cancer ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feczkó, Tivadar, Piiper, Albrecht, Pleli, Thomas, Schmithals, Christian, Denk, Dominic, Hehlgans, Stephanie, Rödel, Franz, Vogl, Thomas J., Wacker, Matthias G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835296/ https://www.ncbi.nlm.nih.gov/pubmed/31548500 http://dx.doi.org/10.3390/pharmaceutics11100489

Ejemplares similares

Selective targeting of tumor associated macrophages in different tumor models
por: Kakoschky, Bianca, et al.
Publicado: (2018)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
por: Köberle, Verena, et al.
Publicado: (2013)

Graphene Oxide as a Nanocarrier for a Theranostics Delivery System of Protocatechuic Acid and Gadolinium/Gold Nanoparticles
por: Usman, Muhammad Sani, et al.
Publicado: (2018)

Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis
por: Waidmann, Oliver, et al.
Publicado: (2020)

Editorial: Functionalized Nanocarriers for Theranostics
por: Leporatti, Stefano, et al.
Publicado: (2020)

Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1
por: Järveläinen, Harri A., et al.
Publicado: (2023)

Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury
por: Scheiermann, Patrick, et al.
Publicado: (2015)

Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
por: Babos, György, et al.
Publicado: (2020)

Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
por: Xing, Hang, et al.
Publicado: (2016)

PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
por: Flores, Orielyz, et al.
Publicado: (2017)

Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery
por: Benizri, Sebastien, et al.
Publicado: (2018)

Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
por: Lin, Gan, et al.
Publicado: (2016)

Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly[ε-caprolactone-co-(12-hydroxystearate)] Copolymer
por: Kántor, Izolda, et al.
Publicado: (2021)

Polymeric Nanocarriers for the Delivery of Antimalarials
por: Mhlwatika, Zandile, et al.
Publicado: (2018)

The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
por: Sancey, L, et al.
Publicado: (2014)

Flavonoid-Conjugated Gadolinium Complexes as Anti-Inflammatory Theranostic Agents
por: Yang, Byeong Woo, et al.
Publicado: (2022)

Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers
por: Beztsinna, Nataliia, et al.
Publicado: (2017)

Polymeric Nanocarriers for Effective Synergistic Action of Sorafenib Tosylate and Gold-sensitized Gamma Radiation Against HepG2 Cells
por: Sukkar, Firas, et al.
Publicado: (2021)

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit(®) RLPO
por: Hajba-Horváth, Eszter, et al.
Publicado: (2021)

Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
por: Hu, Pengcheng, et al.
Publicado: (2019)

Polymeric nanocarrier systems for photodynamic therapy
por: Li, Li, et al.
Publicado: (2014)

Advances in Functionalized Photosensitive Polymeric Nanocarriers
por: Fernández, Maritza, et al.
Publicado: (2021)

Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
por: Mi, Peng
Publicado: (2020)

Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics
por: Gareev, Kamil, et al.
Publicado: (2023)

Polymeric nanocarriers for the treatment of systemic iron overload
por: Hamilton, Jasmine L, et al.
Publicado: (2015)

Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
por: Butowska, Kamila, et al.
Publicado: (2021)

Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery
por: Kesse, Samuel, et al.
Publicado: (2019)

Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
por: Singh, Nem, et al.
Publicado: (2022)

Polyaminoacid Based Core@shell Nanocarriers of 5-Fluorouracil: Synthesis, Properties and Theranostics Application
por: Szczęch, Marta, et al.
Publicado: (2021)

Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
por: Avramović, Nataša, et al.
Publicado: (2020)

Drug Delivery with Polymeric Nanocarriers—Cellular Uptake Mechanisms
por: Nelemans, Levi Collin, et al.
Publicado: (2020)

Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy
por: Jain, Nishant Kumar, et al.
Publicado: (2019)

Serum Autotaxin Is a Parameter for the Severity of Liver Cirrhosis and Overall Survival in Patients with Liver Cirrhosis – A Prospective Cohort Study
por: Pleli, Thomas, et al.
Publicado: (2014)

Click functionalized biocompatible gadolinium oxide core-shell nanocarriers for imaging of breast cancer cells
por: Siribbal, Shifaa M., et al.
Publicado: (2022)

Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment
por: Ali, Imran, et al.
Publicado: (2020)

Gadolinium Retention as a Safety Signal: Experience of a Manufacturer
por: Lancelot, Eric, et al.
Publicado: (2020)

Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages
por: Šimečková, Pavlína, et al.
Publicado: (2020)

AGuIX(®) from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
por: Lux, François, et al.
Publicado: (2019)

Boron and Gadolinium Loaded Fe(3)O(4) Nanocarriers for Potential Application in Neutron Capture Therapy
por: Korolkov, Ilya V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0vhaihioorubnoekuj7b30uk4u